Alexandria Real Estate Equities
ARE
#2443
Rank
$7.40 B
Marketcap
$43.02
Share price
-0.72%
Change (1 day)
-44.43%
Change (1 year)
Alexandria Real Estate Equities, Inc. is a real estate investment trust that invests in office buildings and laboratories.

P/S ratio for Alexandria Real Estate Equities (ARE)

P/S ratio as of October 2026 (TTM): 2.67

According to Alexandria Real Estate Equities 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0.3845. At the end of 2026 the company had a P/S ratio of 3.49.

P/S ratio history for Alexandria Real Estate Equities from 2001 to 2026

PS ratio at the end of each year

Year P/S ratio Change
20263.4921.29%
20252.87-49.01%
20245.64-27.28%
20237.75-16.47%
20229.28-44.49%
202116.730.53%
202012.8-0.49%
201912.932.25%
20189.73-13.23%
201711.214.08%
20169.8322.88%
20158.00-9.14%
20148.8020.55%
20137.300.05%
20127.30-14.75%
20118.56-2.37%
20108.7721.13%
20097.2439.2%
20085.20-48.94%
200710.2-14.54%
200611.926.22%
20059.440.05%
20049.4412.4%
20038.4021.7%
20026.901.27%
20016.81

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
Pfizer
PFE
2.69 0.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
14.2 431.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
6.25 134.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
6.38 139.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
9.31 248.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
2.56-4.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
6.31 136.15%๐Ÿ‡บ๐Ÿ‡ธ USA